New discoveries a natural fit for executive team

Published



Leaky gut, tight junctions, and amucosal biologies drive passions at Alba Therapeutics.

The biopharmaceutical company will develop a drug for those who suffer from Celiac?s Disease ?an allergy to gluten-containing grains that attacks the small intestine. So far, the only “cure” is total elimination of gluten from one?s diet.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.